DL-苯丙氨酸叔丁酯盐酸盐
|
D351599-1g
|
≥97% |
75898-47-4 |
1g
|
¥ 26.9
|
现货 |
阿拉丁 |
4-氨基-4'-甲氧基二苯乙烯
|
A151432-250mg
|
≥97%, mixture of cis and trans |
7570-37-8 |
250mg
|
¥ 278.9
|
期货,请咨询 |
阿拉丁 |
哌南氟酮
|
P333467-5mg
|
Moligand™, ≥97% |
75444-65-4 |
5mg
|
¥ 583.9
|
现货 |
阿拉丁 |
哌南氟酮
|
P333467-100mg
|
Moligand™, ≥97% |
75444-65-4 |
100mg
|
¥ 6422.9
|
现货 |
阿拉丁 |
7-氮杂吲哚-5-羧酸
|
H136030-5g
|
≥97% |
754214-42-1 |
5g
|
¥ 611.9
|
现货 |
阿拉丁 |
7-氮杂吲哚-5-羧酸
|
H136030-25g
|
≥97% |
754214-42-1 |
25g
|
¥ 2644.9
|
现货 |
阿拉丁 |
7-氮杂吲哚-5-羧酸
|
H136030-10g
|
≥97% |
754214-42-1 |
10g
|
¥ 1190.9
|
现货 |
阿拉丁 |
茚达特罗马来酸盐
|
I157518-250mg
|
≥98%(HPLC) |
753498-25-8 |
250mg
|
¥ 2381.9
|
现货 |
阿拉丁 |
盐酸PRE-084
|
P413684-100mg
|
≥99% |
75136-54-8 |
100mg
|
¥ 4531.9
|
现货 |
阿拉丁 |
二氯甲烷
|
D452606-5L
|
精馏级 |
75-09-2 |
5L
|
¥ 335.0
|
现货 |
阿拉丁 |
胆固醇异戊醚
|
C352060-25mg
|
≥98% |
74996-30-8 |
25mg
|
¥ 718.9
|
现货 |
阿拉丁 |
Itanapraced (CHF 5074)
|
I413736-25mg
|
Moligand™, ≥96% |
749269-83-8 |
25mg
|
¥ 1787.9
|
现货 |
阿拉丁 |
Itanapraced (CHF 5074)
|
I413736-100mg
|
Moligand™, ≥96% |
749269-83-8 |
100mg
|
¥ 5938.9
|
现货 |
阿拉丁 |
吡拉西坦
|
P129415-5g
|
Moligand™, ≥98% |
7491-74-9 |
5g
|
¥ 29.9
|
现货 |
阿拉丁 |
吡拉西坦
|
P129415-500g
|
Moligand™, ≥98% |
7491-74-9 |
500g
|
¥ 519.9
|
现货 |
阿拉丁 |
吡拉西坦
|
P129415-25g
|
Moligand™, ≥98% |
7491-74-9 |
25g
|
¥ 39.9
|
现货 |
阿拉丁 |
吡拉西坦
|
P129415-100g
|
Moligand™, ≥98% |
7491-74-9 |
100g
|
¥ 128.9
|
现货 |
阿拉丁 |
2-(1-{(4-氟苯基)氨甲酰]甲基}环己基)乙酸
|
W418465-5mg
|
≥98% |
748146-89-6 |
5mg
|
¥ 833.9
|
现货 |
阿拉丁 |
2-(1-{(4-氟苯基)氨甲酰]甲基}环己基)乙酸
|
W418465-50mg
|
≥98% |
748146-89-6 |
50mg
|
¥ 4943.9
|
现货 |
阿拉丁 |
2-(1-{(4-氟苯基)氨甲酰]甲基}环己基)乙酸
|
W418465-25mg
|
≥98% |
748146-89-6 |
25mg
|
¥ 2779.9
|
现货 |
阿拉丁 |
2-(1-{(4-氟苯基)氨甲酰]甲基}环己基)乙酸
|
W418465-10mg
|
≥98% |
748146-89-6 |
10mg
|
¥ 1389.9
|
现货 |
阿拉丁 |
2-(1-{(4-氟苯基)氨甲酰]甲基}环己基)乙酸
|
W418465-100mg
|
≥98% |
748146-89-6 |
100mg
|
¥ 7136.9
|
现货 |
阿拉丁 |
2-甲氧基苯甲酰肼
|
M357155-5g
|
≥98% |
7466-54-8 |
5g
|
¥ 36.9
|
现货 |
阿拉丁 |
2-甲氧基苯甲酰肼
|
M357155-100g
|
≥98% |
7466-54-8 |
100g
|
¥ 374.9
|
现货 |
阿拉丁 |